Global In-vitro Diagnostics Market - Growth, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022, the in-vitro diagnostics market was valued at USD 60,468.7 Mn in 2015, and is expected to reach USD 81,345.1 Mn by 2022, expanding at a CAGR of 4.2% from 2016 to 2022.
Browse Full Report Visit - http://www.acutemarketreports.com/report/in-vitro-diagnostics-market
Market Insights
The need for in-vitro diagnostics is on a consistent rise due to growing incidence of chronic diseases, infections and high risk ageing population. Growing scope of personalized medicine, molecular diagnostics and growing knowledge about exploration of rare diseases and their treatments are further supporting the growth of in-vitro diagnostics market. On the other hand, rigorous regulatory requirements and dicey reimbursements will hold back the hold of this market.
Reagents, instruments, and software and services is the product level segmentation of the global in-vitro diagnostics market. Among these, reagents take over 30% of the overall market share in 2015, due to large scale consumption of these products across all IVS techniques. Additionally, the software and services segment is anticipated to progress at a faster growth rate during the forecast period attributed by the growing need for widest automation and centralization of IVD processes and techniques at a precision at par.
Molecular diagnostics is observed to be the most remarkable IVD technique during the forecast period. Growing applicability of MDx is attributed to its efficacy in understanding disease mechanism and thus their vital role in discovery of appropriate and targeted treatments. Its prospects in novel drug discovery and personalized medicine also plays a critical role in facilitating lucrative market growth during the forecast period. IVD is largely performed in central laboratories, whereas its applicability in point-of-care testing is on a perpetual growth. However, over-the-counter or self testing IVD will demonstrate the most significant growth rate in the near future with the growing number of OTC testing products while offering cost effectiveness and precise outcomes.
Geographically, North America is the largest in-vitro diagnostics market, with the region taking over 35% market share in 2015. Fastest adoption of advanced technologies and rapid adoption of automation techniques in diagnostic process are the prime features of North America IVD market. Growing preference for molecular diagnostic in cancer screening will also facilitate steady growth to North America and Europe in-vitro diagnostics markets.
This market is majorly dominated with 5 players taking over 5% market share. This market is currently undergoing large scale consolidation activities by multinational players. Emergence of regional players is another significant phenomenon in the global in-vitro diagnostics market. Some of the major market players include Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, bioMérieux, Thermo Fisher Scientific, Inc. Sysmex Corporation and others.
The need for in-vitro diagnostics is on a consistent rise due to growing incidence of chronic diseases, infections and high risk ageing population. Growing scope of personalized medicine, molecular diagnostics and growing knowledge about exploration of rare diseases and their treatments are further supporting the growth of in-vitro diagnostics market. On the other hand, rigorous regulatory requirements and dicey reimbursements will hold back the hold of this market.
Reagents, instruments, and software and services is the product level segmentation of the global in-vitro diagnostics market. Among these, reagents take over 30% of the overall market share in 2015, due to large scale consumption of these products across all IVS techniques. Additionally, the software and services segment is anticipated to progress at a faster growth rate during the forecast period attributed by the growing need for widest automation and centralization of IVD processes and techniques at a precision at par.
Molecular diagnostics is observed to be the most remarkable IVD technique during the forecast period. Growing applicability of MDx is attributed to its efficacy in understanding disease mechanism and thus their vital role in discovery of appropriate and targeted treatments. Its prospects in novel drug discovery and personalized medicine also plays a critical role in facilitating lucrative market growth during the forecast period. IVD is largely performed in central laboratories, whereas its applicability in point-of-care testing is on a perpetual growth. However, over-the-counter or self testing IVD will demonstrate the most significant growth rate in the near future with the growing number of OTC testing products while offering cost effectiveness and precise outcomes.
Geographically, North America is the largest in-vitro diagnostics market, with the region taking over 35% market share in 2015. Fastest adoption of advanced technologies and rapid adoption of automation techniques in diagnostic process are the prime features of North America IVD market. Growing preference for molecular diagnostic in cancer screening will also facilitate steady growth to North America and Europe in-vitro diagnostics markets.
This market is majorly dominated with 5 players taking over 5% market share. This market is currently undergoing large scale consolidation activities by multinational players. Emergence of regional players is another significant phenomenon in the global in-vitro diagnostics market. Some of the major market players include Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, bioMérieux, Thermo Fisher Scientific, Inc. Sysmex Corporation and others.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
2.2 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
2.3 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
2.4 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)
2.1 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
2.2 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
2.3 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
2.4 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)
Chapter 3 In-vitro Diagnostics Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players
Chapter 4 Global In-vitro Diagnostics Market Analysis, by Products
4.1 Preface
4.2 Reagents
4.3 Instruments
4.4 Software and Services
4.1 Preface
4.2 Reagents
4.3 Instruments
4.4 Software and Services
Chapter 5 Global In-vitro Diagnostics Market Analysis, by Techniques
5.1 Preface
5.2 Clinical Chemistry
5.3 Immunochemistry/Immunoassays
5.4 Hematology
5.5 Coagulation and Hemostasis
5.6 Microbiology
5.7 Molecular Diagnostics (MDX)
5.8 Others
5.1 Preface
5.2 Clinical Chemistry
5.3 Immunochemistry/Immunoassays
5.4 Hematology
5.5 Coagulation and Hemostasis
5.6 Microbiology
5.7 Molecular Diagnostics (MDX)
5.8 Others
Chapter 6 Global In-vitro Diagnostics Market Analysis, by Test Locations
6.1 Preface
6.2 Point-of-Care Testing
6.3 Central Lab Testing
6.4 OTC/Self Testing
6.1 Preface
6.2 Point-of-Care Testing
6.3 Central Lab Testing
6.4 OTC/Self Testing
Chapter 7 Global In-vitro Diagnostics Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America
To Get Complete Report @ http://www.acutemarketreports.com/report/in-vitro-diagnostics-market
Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 News Coverage
8.2 Bayer AG.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 News Coverage
8.3 Becton, Dickson and Company
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 News Coverage
8.4 bioMérieux
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 News Coverage
8.2 Bayer AG.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 News Coverage
8.3 Becton, Dickson and Company
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 News Coverage
8.4 bioMérieux
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
Our Blog :- http://www.pdfdevices.com/
No comments:
Post a Comment